Member Info for cash2

Anyone remember the 2016 debacle - it dropped all the way to 0.35 p and then rose to 6p at its highest. I have a feeling there will be a similar trend given the success that lies ahead. AIM will drop it simply because it can. I guess, looking ahead, let's not forget all eyes on the prize - April it is !

Codx in the US is waiting for fda approval too. So there is competition. You might want to check its status on Nasdaq. It recently received CE mark approval. Getting the US nod may not be that easy

Yep but this product is not about containment - it is a detection kit. So how relevant ?

As the virus is getting worse, the focus will be on finding a cure rather than a prevention kit. So how does ncyt benefit from this ? Wouldn’t it be companies finding vaccines that stand a better chance of seeing share price increases ?

Coronavirus: 'Narrowing window' to contain outbreak, WHO says https://www.bbc.co.uk/news/world-asia-51591091

A lot of people are posting articles but this recent bbc one is worrying - very worrying about this being contained

59 - 60 pence was IPO price - just a point to bear in mind. Now money is coming in, products sold and eyes on the company

And there u go midas just confirmed my point

If u believe in share prophets u probably believe in santa clause too

If u believe in ************* you probably believe in Santa Claus too

Don’t think so- what other pies are you talking about ?

I don’t think it can only go up from here. It needs positive news on fda and sales. In addition a different marketing strategy if that’s what the ceo had to say

Lb what was the deal with eua. You seem to refer to that a lot. Would you be able to explain what happened ?

This reminds me a lot of Iqai similarity when it had the fda approval and kept on rising .. this is not exactly the same but you can draw similarities ??

yeah but that's nothing really considering that the 17 feb milestone may not have been met, could have been postponed etc. I think this is where it may start to get interesting as a date has been set and all eyes on the next steps. Let's see.

I think it's important to draw somewhat of a parallel with what is happening with US stocks - those stocks working on vaccines, masks and other treatment - CODX, NNVC, NVAX, IBIO, INO - they have all risen from January owing to Corona - look at CODX - rose from around 1 dollar to 4 - NNVC from 2 dollars to 18 dollars - INO is still going strong - but it is very much dependent on progress, anticipation, further news and Corona developments too.

So, how does that relate to NCYT - well for the same reason - progress, anticipation, delivery, etc - while I don't think this parallel is an absolute guarantee NCYT will rise in a similar manner, you've got to be daft to not see a link or as I said above, somewhat of a parallel - let's see what forthcoming news brings, in particular next week !

Don’t think it’s really about today’s close - more to do with forthcoming news and its impact - a sniff of fda approval or success with the kits will see this hit significant highs. This is my interpretation of how bios work

I genuinely hope investors have learnt a lot here in particular when the board’s reputation was being questioned for a long while. Those taking a justifiable critical look were unfairly criticised. It was all about optimism and hope and averaging down. Well naybe now the truth is out and lessons have been learnt for all those continuing to glorify the share for no reason

Isn’t 4 pence conservative ?

Boom 2- I think with this being an appraisal well, it’s different. Not like ice 1. The hype is there but the hype is most likely to be real.

Jamie - I owe you an apology. As I said I would, if the RNS turned out good. It is. This has a long way to go yet as 5 pence is cheap but at least the company is looking to be a producer.

ATB with your investments Jamie !